Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
45 participants
INTERVENTIONAL
2024-05-23
2025-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study endpoints
Primary Endpoint:
Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions.
Secondary endpoints:
* Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions.
* Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)
* Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5
* Time to reaching an Oxygen Reserve Index (ORi) =1
* Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.
Number of participants 15 participants per subgroup, i.e. 45 participants in total.
Inclusion criteria
* Normal-weight adults (body mass index, BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II
* Adults with a BMI 25-39.9 kg/m2 with and ASA score \<3
* Healthy (ASA I) children aged 6-12 years Exclusion criteria ASA 3, Age \< 6 and age 12-18, pregnant women, missing informed consent, signs and symptoms of an acute respiratory illness on the study day.
After informed consent and a medical check-up, baseline measurements will be done for 10 minutes (peripheral oxygen saturation SpO2, ORI, regional ventilation). Then the participants will undergo 3 different preoxygenation sessions with the 3 interfaces (i.e. non-rebreather facemask with reservoir and a bag-valve-mask with and without PEEP) in a randomized order and a 20 min washout between the sessions. Each preoxygenation session is conducted in a supine position and will be proceeded until the measured FeO2 (end expiratory O2 fraction) reaches 90% or up to a maximum time of 3 min. Afterwards 10 min of SpO2, ORI and regional ventilation measurements will follow.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Preoxygenation Strategies in the Prehospital Environment
NCT02694705
Automatic Ventilation in Prehospital Resuscitation on OHCA
NCT06067204
Pre-oxygenation With Real Time End-tidal Oxygen Measurements Versus Single Breath Measurements
NCT03840486
Preoxygenation Using THRIVE Versus Facemask in Parturients
NCT03772574
Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry
NCT06283914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NRM - Non-rebreather mask in children 6-12 yrs
Non-rebreather mask in children 6-12 yrs
Preoxygenation
Preoxygenation of volunteers over 3 minutes
BVM with PEEP in children 6-12 yrs
Bag valve mask with positive end-expiratory pressure (PEEP) in children 6-12 yrs
Preoxygenation
Preoxygenation of volunteers over 3 minutes
BVM without PEEP in children 6-12 yrs
Bag valve mask without positive end-expiratory pressure (PEEP) in children 6-12 yrs
Preoxygenation
Preoxygenation of volunteers over 3 minutes
NRM - Non-rebreather mask in normal weight adults
Non-rebreather mask in normal weight adults
Preoxygenation
Preoxygenation of volunteers over 3 minutes
BVM with PEEP in normal weight adults
Bag valve mask with positive end-expiratory pressure (PEEP) in normal weight adults
Preoxygenation
Preoxygenation of volunteers over 3 minutes
BVM without PEEP in normal weight adults
Bag valve mask without positive end-expiratory pressure (PEEP) in normal weight adults
Preoxygenation
Preoxygenation of volunteers over 3 minutes
NRM - Non-rebreather mask in overweight/obese adults
Non-rebreather mask in overweight/obese adults
Preoxygenation
Preoxygenation of volunteers over 3 minutes
BVM with PEEP in overweight/obese adults
Bag valve mask with positive end-expiratory pressure (PEEP) in overweight/obese adults
Preoxygenation
Preoxygenation of volunteers over 3 minutes
BVM without PEEP in overweight/obese adults
Bag valve mask without positive end-expiratory pressure (PEEP) in overweight/obese adults
Preoxygenation
Preoxygenation of volunteers over 3 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Preoxygenation
Preoxygenation of volunteers over 3 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults with a BMI 25-39.9 kg/m2 with and ASA score \<3
* Healthy (ASA I) children aged 6-12 years
Exclusion Criteria
* Age \< 6 and age 12-18
* pregnant women
* missing informed consent
* signs and symptoms of an acute respiratory illness on the study day
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Mountain Emergency Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon Rauch, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Mountain Emergency Medicine, Eurac Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TerraXCube
Bolzano, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Roveri G, Camporesi A, Hofer A, Kahlen S, Breidt F, Rauch S. Preoxygenation With and Without Positive End-Expiratory Pressure in Lung-Healthy Volunteers: A Randomized Clinical Trial. JAMA Netw Open. 2025 May 1;8(5):e2511569. doi: 10.1001/jamanetworkopen.2025.11569.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRE-OX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.